We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

New Enterovirus Monoclonal Antibodies

Product News   Mar 08, 2014

 
New Enterovirus Monoclonal Antibodies
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Phase I/II Clinical Trial of COVID-19 Vaccine Begins

Product News

Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced enrollment of the first participants in a Phase 1/2 clinical trial of its coronavirus vaccine candidate, NVX‑CoV2373, a stable, prefusion protein made using its proprietary nanoparticle technology.

READ MORE

New Neuroinflammation Discovery Services Offer Advanced Insight into Chronic Pain

Product News

Cellectricon has announced the launch of services offering for exploration of the role of neuroinflammation in chronic pain.

READ MORE

300 Antibodies Generated That Have Neutralization Potential Against SARS-CoV-2

Product News

Prellis Biologics, Inc. announced that it has generated 300 human IgG antibodies that bind to either the S1 or S2 spike protein of the SARS-CoV2-Wuhan strain of the novel coronavirus.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE